Publication
Title
An expert roundtable discussion on the use of classic monoamine oxidase inhibitors in the treatment of depression : part two
Author
Abstract
Experienced clinicians and academics from the International MAOI Expert Group comment on questions of interest concerning monoamine oxidase inhibitor (MAOI) pharmacotherapy for depression. These comments in this Part Two of the Expert Roundtable Discussion emphasize good pharmacological practice, starting with a low dose and progressing slowly and only changing one element at a time. Issues related to augmentation and drug combinations are also mentioned, including comments about the safety of ketamine. The special ability of MAOIs to improve dopamine function is highlighted, especially in relation to melancholic and psychotic depression. [Psychiatr Ann. 2023;53(8):364-369.]
Language
English
Source (journal)
Psychiatric annals
Publication
2023
ISSN
0048-5713
1938-2456
DOI
10.3928/00485713-20230718-01
Volume/pages
53 :8 (2023) , p. 364-369
ISI
001051488600006
Full text (Publisher's DOI)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identifier
Creation 02.10.2023
Last edited 12.10.2023
To cite this reference